 |
|
|
|
|
|
|
|
|
|
|
|
1 to 10 of 10 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Kumar-Singh S. on PAPER: Pelletier S. et al., 2012, Pelletier and colleagues show that a constitutive loss of function of Scyl1 in newly established... 3 Dec 2012.
|
|
|
 |
|
|
Kumar-Singh S. on PAPER: Shan X. et al., 2010, This is a fascinating study on yet another TDP-43 transgenic mouse model
driven by the mouse... 16 Sep 2010.
|
|
|
|
|
|
Kumar-Singh S. on NEWS: Meet the First Published TDP-43 Mouse, This study elegantly gives a first insight on a transgenic mouse model of mutant TDP-43 (A315T)... 16 Oct 2009.
|
|
|
|
|
|
Kumar-Singh S. on PAPER: Yan P. et al., 2009, Yan and colleagues add another piece to the plaque kinetics puzzle by showing, with on... 2 Sep 2009.
|
|
|
|
|
|
Kumar-Singh S. on PAPER: Tatom JB. et al., 2009, The issue of whether overexpression of wild-type TDP-43 in rodent brain could be neurotoxic is... 7 Mar 2009.
|
|
|
|
|
|
Kumar-Singh S. on PAPER: Bolmont T. et al., 2008, This is a fascinating paper from the group of Mathias Jucker and Michael Calhoun studying in... 21 Apr 2008.
|
|
|
|
|
|
Kumar-Singh S. on PAPER: Meyer-Luehmann M. et al., 2008, This is another state-of-the-art paper by the group active on in vivo two-photon imaging on... 9 Feb 2008.
|
|
|
|
|
|
Kumar-Singh S. on LIVE DISCUSSION: Presenilin Loss of Function—Plan B for AD?, Closing Comment
I think the reviews and commentaries posted on this Forum Discussion... 23 May 2007.
|
|
|
|
|
|
Kumar-Singh S. on LIVE DISCUSSION: Gain or Loss of Function—Time to Shake up Assumptions on γ-Secretase in Alzheimer Disease?, Drs. Davis, De Strooper, and Gabrielle Strobel have done a superb job in taking the initiative... 24 Jan 2007.
|
|
|
|
|
|
Kumar-Singh S. on NEWS: Amyloid-β—On or off the Wall?, Regarding Dr. D’Andrea’s remarks, we studied only ThS-positive “dense” plaques and not diffuse... 12 Sep 2005.
|
|
|
|
|
|
|
1 to 10 of 10 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
See our latest Webinar: 
